Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Sales | 3,350 | 4,730 | 3,140 | 3,230 | 4,016 |
| Gross Profit | 3,350 | 4,730 | 3,140 | 3,230 | 4,016 |
| Operating Expenses | 24,620 | 32,880 | 33,650 | 24,350 | 0 |
| Operating Income | -21,270 | -28,150 | -30,510 | -21,120 | 4,016 |
| Interest Expense | 20 | 0 | 0 | 30 | 0 |
| Other Income | 1,260 | 2,960 | 0 | -10 | 0 |
| Pre-tax Income | -20,030 | -25,190 | -30,510 | -21,160 | 4,016 |
| Income Tax | -180 | -200 | -280 | 10 | 0 |
| Net Income Continuous | -19,985 | -24,991 | -30,302 | -31,432 | -15,135 |
| Net Income Discontinuous | 0 | 0 | 0 | 0 | -941 |
| Net Income | $-19,850 | $-24,980 | $-30,230 | $-21,180 | $-16,076 |
| EPS Basic Total Ops | -15.47 | -17.27 | -22.67 | -25.55 | -12.96 |
| EPS Basic Continuous Ops | -13.57 | -17.46 | -22.53 | -25.48 | -12.29 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.76 |
| EPS Diluted Total Ops | -15.47 | -17.27 | -22.67 | -25.55 | -12.96 |
| EPS Diluted Continuous Ops | -13.57 | -17.46 | -22.53 | -25.48 | -12.29 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.76 |
| EBITDA(a) | $-20,420 | $-27,320 | $-29,670 | $-20,410 | $4,016 |